Zneof Thelargest Medicinemanufacturers In Russiabinnopharm Group Was Created In 2020 Through Consolidation Of Pharmaceutical Assets Of Sistemathegroup Boasts Fiveplantswhich Producean Extensiverangeof Prescription And Otc Medicines Thegroup Has Over 450 Marketing Authorisations In Russiamorethan 100 Medicines Included In In Thelist Of Vital And Essential Medicineswith Fiveplants Across Russiabinnopharm Group Has Thelargest Area Of Medicineproduction Capacity In Russiabinnopharm Group Facilities Manufacturemedicines In All Dosageformsfrom Tablets And Capsules To Spraysinjectionsand Suppositories20Of Theproducts Aremadefrom Thegroup S Own Activepharmaceutical Ingredients Binnopharm Group Medicines Areprocured Under Government Tenderssold In Theretail Pharmaceutical Marketand Also Exported To 14 Countries Worldwidethegroup Is Oneof Thelargest Suppliers For Theinpatient Segmentproviding Clinics And Hospitals With Antibiotics In Various Dosageformsmedicines For Endocrinologyneurologycardiology And Other Therapeutic Groupsand Medical Devices For Blood Transfusion Binnopharm Group Makes High Qualityeffectiveand Safemedical Products And Adhering To Gmp Standards Thegroup S Products Arealso Availablein 14 Countriesofficial Representativeoffices Of Binnopharm Group Havebeen Opened In 6 Cis Countries And China Binnopharm Group Constantly Develops New Products And Expands Its Portfolioin 202 Thegroup Opens An Advanced R&D Center In Russiawith A Total Floor Area Of 12 000 Sq Mby 2025Binnopharm Group Is Set To Market Over 100 Medical Products For Such Diseaseareas As Dermatologyneurologygynaecologypaediatricsetc Human Capital Development Along With Constant Upgrades Of Production Capacitiesimprovement Of R&D Competenciesand Adherenceto Theworld S Top Quality Control Standards Is What Underpins Binnopharm Group S Operations
